ASSOCIATION BETWEEN GENOTYPE AND BASELINE HBsAg LEVELS AND THE HBsAg LEVELS AT HBeAg SEROCLEARANCE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR

被引：0
|
作者：
Peng, C. -Y. [1 ]
Lai, H. -C. [1 ]
Su, W. -P. [1 ]
Lin, C. -H. [1 ]
Chuang, P. -H. [1 ]
Chen, S. -H. [1 ]
机构：
[1] China Med Univ Hosp, Dept Internal Med, Div Hepatogastroenterol, Taichung, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)61220-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1060
引用
收藏
页码：S430 / S430
页数：1
相关论文
共 50 条
  • [21] Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B
    Cheng, Pin-Nan
    Tsai, Hung-Wen
    Chiu, Yen-Cheng
    Ho, Cheng-Hsun
    Wu, I-Chin
    Chang, Ting-Tsung
    JOURNAL OF CLINICAL VIROLOGY, 2013, 57 (04) : 323 - 330
  • [22] Efficacy of telbivudine in HBeAg-positive chronic hepatitis B patients with high baseline ALT levels
    Guo-Cai Lv
    World Journal of Gastroenterology, 2010, 16 (32) : 4095 - 4099
  • [23] On-treatment HBV DNA level could predict HBeAg seroclearance in patients with HBeAg-positive chronic hepatitis B with entecavir therapy
    Huang, Yi-Jie
    Chang, Chi-Sen
    Peng, Yen-Chun
    Yeh, Hong-Zen
    Yang, Sheng-Shun
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2017, 80 (06) : 341 - 346
  • [24] Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients (vol 8, e21444, 2015)
    Sharafi, Heidar
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (12)
  • [25] HBsAg and HBV DNA levels guiding entecavir cessation in HBeAg-negative chronic hepatitis B
    Seto, Wai-Kay
    Hui, Aric Josun
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    Liu, Kevin
    Lai, Ching-Lung
    Yuen, Man-Fung
    Chan, Henry Lik-Yuen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 414 - 414
  • [26] Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B
    Gish, R. G.
    Chang, T. -T.
    Lai, C. -L.
    de Man, R.
    Gadano, A.
    Poordad, F.
    Yang, J.
    Brett-Smith, H.
    Tamez, R.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (01) : 16 - 22
  • [27] Association between KIR Genes and Efficacy of Treatment of HBeAg-Positive Chronic Hepatitis B Patients with Entecavir
    Zhuang, Yun-Long
    Li, Xi-Xi
    Xu, Hui-Cong
    Ye, Hui
    Sun, Di
    Liu, Xiang-Zhong
    Ren, Gui-Jie
    IRANIAN JOURNAL OF IMMUNOLOGY, 2018, 15 (02) : 112 - 121
  • [28] Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients
    Chen, Gong-Ying
    Zhu, Meng-Fei
    Zheng, Da-Liang
    Bao, Yan-Ting
    Wang, Jie
    Zhou, Xiang
    Lou, Guo-Qiang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (25) : 8195 - 8200
  • [29] Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients
    Gong-Ying Chen
    Meng-Fei Zhu
    Da-Liang Zheng
    Yan-Ting Bao
    Jie Wang
    Xiang Zhou
    Guo-Qiang Lou
    World Journal of Gastroenterology, 2014, (25) : 8195 - 8200
  • [30] PREDICTION OF RESPONSE TO PEGINTERFERON FOR HBEAG-POSITIVE CHRONIC HEPATITIS B USING QUANTITATIVE SEROLOGY: HBEAG VERSUS HBSAG
    Sonneveld, M. J.
    Rijckborst, V.
    Hansen, B. E.
    Janssen, H. L.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S215 - S216
12345